Sanofi’s Revamped Business Structure Includes Three New Pharma Units
This article was originally published in The Tan Sheet
Executive Summary
The French pharma said it will operate with five global business units beginning in January 2016: General Medicines & Emerging Markets, Specialty Care, Diabetes & Cardiovascular, Sanofi Pasteur and Merial.